251 related articles for article (PubMed ID: 14968119)
1. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis.
Menon AG; Janssen-van Rhijn CM; Morreau H; Putter H; Tollenaar RA; van de Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2004 Apr; 84(4):493-501. PubMed ID: 14968119
[TBL] [Abstract][Full Text] [Related]
2. A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.
Menon AG; Fleuren GJ; Alphenaar EA; Jonges LE; Janssen van Rhijn CM; Ensink NG; Putter H; Tollenaar RA; van de Velde CJ; Kuppen PJ
Cancer Immunol Immunother; 2003 Feb; 52(2):121-6. PubMed ID: 12594576
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells.
Dadabayev AR; Sandel MH; Menon AG; Morreau H; Melief CJ; Offringa R; van der Burg SH; Janssen-van Rhijn C; Ensink NG; Tollenaar RA; van de Velde CJ; Kuppen PJ
Cancer Immunol Immunother; 2004 Nov; 53(11):978-86. PubMed ID: 15197496
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.
Menon AG; Morreau H; Tollenaar RA; Alphenaar E; Van Puijenbroek M; Putter H; Janssen-Van Rhijn CM; Van De Velde CJ; Fleuren GJ; Kuppen PJ
Lab Invest; 2002 Dec; 82(12):1725-33. PubMed ID: 12480922
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
[TBL] [Abstract][Full Text] [Related]
9. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
[TBL] [Abstract][Full Text] [Related]
10. The intratumoural subsite and relation of CD8(+) and FOXP3(+) T lymphocytes in colorectal cancer provide important prognostic clues.
Ling A; Edin S; Wikberg ML; Öberg Å; Palmqvist R
Br J Cancer; 2014 May; 110(10):2551-9. PubMed ID: 24675384
[TBL] [Abstract][Full Text] [Related]
11. Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer.
Okada T; Iiai T; Kawachi Y; Moroda T; Takii Y; Hatakeyama K; Abo T
Clin Exp Immunol; 1995 Oct; 102(1):159-66. PubMed ID: 7554383
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Immune Interaction on the Metastatic Infiltration of Colorectal Carcinoma to Lymph Nodes.
Vycital O; Dubova M; Palek R; Hosek P; Branzovsky J; Treska V; Daum O; Liska V
Anticancer Res; 2018 Jul; 38(7):4159-4167. PubMed ID: 29970545
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.
Lee SY; Miyai K; Han HS; Hwang DY; Seong MK; Chung H; Jung BH; Devaraj B; McGuire KL; Carethers JM
Dig Dis Sci; 2012 Jan; 57(1):72-8. PubMed ID: 21773681
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.
Dolcetti R; Viel A; Doglioni C; Russo A; Guidoboni M; Capozzi E; Vecchiato N; Macrì E; Fornasarig M; Boiocchi M
Am J Pathol; 1999 Jun; 154(6):1805-13. PubMed ID: 10362805
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.
Diederichsen AC; Hjelmborg Jv; Christensen PB; Zeuthen J; Fenger C
Cancer Immunol Immunother; 2003 Jul; 52(7):423-8. PubMed ID: 12695859
[TBL] [Abstract][Full Text] [Related]
16. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
[TBL] [Abstract][Full Text] [Related]
17. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.
Chaput N; Svrcek M; Aupérin A; Locher C; Drusch F; Malka D; Taïeb J; Goéré D; Ducreux M; Boige V
Br J Cancer; 2013 Aug; 109(4):1013-22. PubMed ID: 23868006
[TBL] [Abstract][Full Text] [Related]
18. Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.
Callahan MJ; Nagymanyoki Z; Bonome T; Johnson ME; Litkouhi B; Sullivan EH; Hirsch MS; Matulonis UA; Liu J; Birrer MJ; Berkowitz RS; Mok SC
Clin Cancer Res; 2008 Dec; 14(23):7667-73. PubMed ID: 19047092
[TBL] [Abstract][Full Text] [Related]
19. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.
Tsuchikawa T; Ikeda H; Cho Y; Miyamoto M; Shichinohe T; Hirano S; Kondo S
Clin Exp Immunol; 2011 Apr; 164(1):50-6. PubMed ID: 21352198
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis.
Li K; Mandai M; Hamanishi J; Matsumura N; Suzuki A; Yagi H; Yamaguchi K; Baba T; Fujii S; Konishi I
Cancer Immunol Immunother; 2009 May; 58(5):641-52. PubMed ID: 18791713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
